Home
Resource
Application of fragment screening by X-ray crystallography for the identification of novel chemical scaffolds targeting viral proteins of HIV and influenza
PDF
PDF format is widely accepted and good for printing.
Plug-in required
PDF-1(19.62 MB)
Citation & Export
View Usage Statistics
Staff View

Citation & Export
Hide

Simple citation

Patel, Disha. Application of fragment screening by X-ray crystallography for the identification of novel chemical scaffolds targeting viral proteins of HIV and influenza. Retrieved from https://doi.org/doi:10.7282/T34F1NSC

Export

Click here for information about Citation Management Tools at Rutgers.

Statistics
Hide

Description

TitleApplication of fragment screening by X-ray crystallography for the identification of novel chemical scaffolds targeting viral proteins of HIV and influenza
NamePatel, Disha (author); Arnold, Eddy (chair); Lavoie, Edmond (internal member); Hu, Longqin (internal member); Marcotrigiano, Joseph (outside member); Rutgers University; Graduate School - New Brunswick
Date Created2013
Other Date2013-10 (degree)
SubjectMedicinal Chemistry, X-ray crystallography, HIV (Viruses), Proteins--Affinity labeling, Viral proteins, Influenza--Research
Extentxx, 169 p. : ill.
DescriptionFragment-based drug discovery (FBDD) is a relatively new approach for discovery of small molecule ligands for subsequent lead development. Here, libraries of relatively small molecules or fragments are screened against a target protein to identify hits with relatively weak binding affinity. Several approaches, which include fragment linking, merging, and expansion, can then be utilized to develop these hits into lead candidates. The intrinsically weak binding affinity of fragments requires screening techniques capable of detecting very weak non-covalent interactions with the protein. Biophysical methods, such as nuclear magnetic resonance (NMR), X-ray crystallography, and surface plasmon resonance (SPR), have been traditionally used for FBDD. X-ray crystallography, in particular, has been underappreciated due to major drawbacks associated with low throughput and labor associated. However, advancements in rapid, automated data collection has improved the throughput and reduced the labor associated with this approach. This thesis reports the development of a high throughput screening method using X-ray crystallography and its successful application as a primary screening tool to identify new compounds for lead development against viral drug targets. Specifically, screening was conducted against HIV-1 reverse transcriptase (RT), the catalytic core domain of HIV-1 integrase (IN CCD), and the cap-snatching endonuclease domain of influenza A. Screening revealed fragment binding to promising, druggable allosteric sites within HIV-1 RT and IN CDD. The availability of a three dimensional structure proved to be highly advantageous as it allowed for structure-based drug design (SBDD) to be pursued. Using this approach, a fragment hit identified to bind to the endonuclease domain of influenza was developed into a new class of endonuclease inhibitors with antiviral activity. This thesis not only details the results from each of the screening campaign but also highlights many key advantages of crystallographic fragment screening.
NotePh.D.
NoteIncludes bibliographical references
Noteby Disha Patel
Genretheses, ETD doctoral
Persistent URLhttps://doi.org/doi:10.7282/T34F1NSC
Languageeng
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.
Version 8.5.5
Rutgers University Libraries - Copyright ©2024